Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 3.
Order by Relevance | Date
Total 2010 results found since Jan 2013.
Herpes Vaccine Safe in Patients With Arthritis on BiologicsHerpes Vaccine Safe in Patients With Arthritis on Biologics
Patients with autoimmune and inflammatory diseases are more prone to getting herpes zoster than the general population, but these patients can be safely vaccinated, a new study has suggested. Medscape Medical News
Source: Medscape Medical News Headlines - November 28, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Vaccine Uptake Among Adults Better, but Still LowVaccine Uptake Among Adults Better, but Still Low
In 2013, adult uptake for herpes zoster, Tdap, and HPV vaccines increased slightly, but others did not, according to a CDC report. Medscape Medical News
Source: Medscape Medical News Headlines - February 6, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Newer Herpes Zoster Vaccine Effective Even in Older AdultsNewer Herpes Zoster Vaccine Effective Even in Older Adults
A recombinant subunit vaccine significantly lowered the risk for herpes zoster in adults aged 50 years or older, with comparable efficacy in adults aged 70 years or older. Medscape Medical News
Source: Medscape Medical News Headlines - April 30, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Shingles Vaccination Helps Some Who Later Develop the Virus Shingles Vaccination Helps Some Who Later Develop the Virus
Adults who developed herpes zoster despite having received the herpes zoster vaccine had a reduced risk for painful complications compared with their unvaccinated counterparts. Medscape Medical News
Source: Medscape Medical News Headlines - June 15, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Routine Shingles Vaccination in 50-Year-Olds Does Not Pay Routine Shingles Vaccination in 50-Year-Olds Does Not Pay
A new study supported the Advisory Committee on Immunization Practices recommendation that routine immunization against herpes zoster in immunocompetent adults should begin at age 60 years. Medscape Medical News
Source: Medscape Medical News Headlines - September 9, 2015 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
Medical News Today: Asthma linked to increased risk of shingles
A new study finds that asthma is a risk factor for herpes zoster or shingles in adults and suggests considering the over-50s with asthma as a target group for zoster vaccination.
Source: Health News from Medical News Today - December 29, 2015 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news
New Shingles Vaccine May Have Higher Efficacy in Older Adults New Shingles Vaccine May Have Higher Efficacy in Older Adults
Phase 3 clinical trial data showed the new shingles vaccine HZ/su is safe and greatly reduces the risk for shingles and postherpetic neuralgia in people 70 years and older.Medscape Medical News
Source: Medscape Medical News Headlines - September 15, 2016 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Gaps Remain in Recommended Vaccines for Older Americans Gaps Remain in Recommended Vaccines for Older Americans
New data suggest room for improvement in influenza, pneumococcal, tetanus, and shingles vaccine coverage among adults aged 65 and older.Medscape Medical News
Source: Medscape Medical News Headlines - June 28, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Analysis Strengthens Herpes Zoster Link With Stroke, MI Analysis Strengthens Herpes Zoster Link With Stroke, MI
More research is needed to elucidate the effect of antiviral-agent use or vaccination on cardiovascular outcomes after herpes zoster infection, the authors said.Medscape Medical News
Source: Medscape Medical News Headlines - July 11, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
FDA Panel Recommends New Shingles Vaccine FDA Panel Recommends New Shingles Vaccine
An FDA panel unanimously recommended zoster vaccine recombinant (adjuvanted) (Shingrix, GlaxoSmithKline) for adults aged 50 years and older.Medscape Medical News
Source: Medscape Medical News Headlines - September 13, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Herpes zoster incidence and cost in patients receiving autologous hematopoietic stem-cell transplant.
CONCLUSIONS: HZ incidence was high despite AP use. Mean annual health care costs were higher for patients with HZ but the difference was not statistically significant. An effective vaccine against HZ could be useful in decreasing both incidence of and cost for HZ in this population.
PMID: 28945107 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - September 27, 2017 Category: Research Tags: Curr Med Res Opin Source Type: research
Most Physicians Say Shingrix Important Development for Shingles Most Physicians Say Shingrix Important Development for Shingles
Although many primary care providers were unfamiliar with the shingles vaccine, they were impressed with it after they learned about it.Medscape Medical News
Source: Medscape Medical News Headlines - October 11, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
ACIP Narrowly Recommends Shingrix for Shingles Over Zostavax ACIP Narrowly Recommends Shingrix for Shingles Over Zostavax
As a whole, the CDC panel is sold on the new recombinant vaccine to prevent herpes zoster, but some members want more safety data before they endorse it over Zostavax.Medscape Medical News
Source: Medscape Medical News Headlines - October 25, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Newer Shingles Vaccine Cheaper, More Effective Newer Shingles Vaccine Cheaper, More Effective
A novel adjuvanted herpes zoster vaccine is likely to be more effective and cheaper than the live attenuated herpes zoster vaccine, a study found.Medscape Medical News
Source: Medscape Medical News Headlines - January 3, 2018 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
2018 Adult ACIP Schedule Highlights New Shingles Vaccine 2018 Adult ACIP Schedule Highlights New Shingles Vaccine
The new recommendations also address the use of an extra dose of measles, mumps, and rubella vaccine during mumps outbreaks.Medscape Medical News
Source: Medscape Medical News Headlines - February 5, 2018 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
